Midostaurin and Xospata drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Midostaurin (midostaurin) and Xospata (gilteritinib). Common drug interactions include iron overload among females and dermatitis acneiform among males.
The phase IV clinical study analyzes what interactions people have when they take Midostaurin and Xospata. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Midostaurin?
Midostaurin has active ingredients of midostaurin. eHealthMe is studying from 1,137 Midostaurin users. Check the latest studies of Midostaurin.
What is Xospata?
Xospata has active ingredients of gilteritinib. eHealthMe is studying from 2,411 Xospata users. Check the latest studies of Xospata.
20 people who take Midostaurin and Xospata together, and have interactions are studied.

What are the common drug interactions of Midostaurin and Xospata, by gender? *:
female:
- Iron overload
- Disease progression
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Anaemia macrocytic (a macrocytic class of anaemia)
- Blood alkaline phosphatase increased
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Alanine aminotransferase increased
male:
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Diarrhoea
- Hepatic enzyme increased
- Folliculitis (infection of hair root)
- Graft versus host disease in liver (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the liver)
- Rash
- Splenomegaly (enlargement of spleen)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Pericarditis (inflammation of the pericardium)
- Bacterial infection
What are the common drug interactions of Midostaurin and Xospata, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Diarrhoea
- Folliculitis (infection of hair root)
- Graft versus host disease in liver (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the liver)
- Rash
- Splenomegaly (enlargement of spleen)
- Alanine aminotransferase increased
- Blast cell count increased
- Liver disorder (liver diseases)
30-39:
- Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
- Ejection fraction decreased (systolic heart failure)
- Monocytosis (an increase in the number of monocytes circulating in the blood)
- Nodule (a growth of abnormal tissue)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Pulmonary alveolar haemorrhage (acute bleeding)
- Subdural haemorrhage (bleeding between the skull and the surface of the brain)
40-49:
- Haemoglobin decreased
- Neutropenia (an abnormally low number of neutrophils)
- Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
- Thrombocytopenia (decrease of platelets in blood)
50-59:
- Iron overload
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Bacterial infection
- Fall
- Hepatic enzyme increased
60+:
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Disease progression
- Skin mass
- Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
- Anaemia macrocytic (a macrocytic class of anaemia)
- Blood alkaline phosphatase increased
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Pericarditis (inflammation of the pericardium)
- Fatigue (feeling of tiredness)
What are the existing conditions these people have? *
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 45.00%
- Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 3 people, 15.00%
- Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.00%
- Graft Versus Host Disease In Liver (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the liver): 1 person, 5.00%
- Acute Myelomonocytic Leukaemia (cancer of the blood-forming organs): 1 person, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Midostaurin and Xospata?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Midostaurin (1,137 reports)
- Xospata (2,411 reports)
Browse all drug interactions of Midostaurin and Xospata:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Midostaurin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Xospata:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Midostaurin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xospata and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on midostaurin and gilteritinib (the active ingredients of Midostaurin and Xospata, respectively), and Midostaurin and Xospata (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Orencia and Naproxen Sodium - 5 seconds ago
- Drug interactions of Charcoal and Melatonin - 16 seconds ago
- Could Ergocalciferol cause Sputum Discolored? - 17 seconds ago
- Could Tivicay cause Mania? - 19 seconds ago
- Primary Pulmonary Hypertension and Gallbladder Operation - 24 seconds ago
- Could Rabeprazole Sodium cause Nephrogenic Anaemia? - 35 seconds ago
- Drug interactions of Rabeprazole Sodium and Pyridoxal - 43 seconds ago
- Could Zonisamide cause Drop Attacks? - 49 seconds ago
- Drug interactions of Levocarnitine and Pregabalin - a minute ago
- Could Tranexamic Acid cause Procedural Haemorrhage? - a minute ago